Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7490]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7486]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7487]
Custodio JM. J Clin Pharmacol. Jun 2014; 54(6): 649-56 Pubmed[6670]
Custodio JM. Pharmacol Res Perspect. Oct 2017; 5(5) Pubmed, Volltext, DOI[7437]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7483]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7484]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7485]
Czuczwar M. Pol J Pharmacol. Sep 2003; 55(5): 799-802 Pubmed[759]
Czuczwar SJ. Expert Opin Drug Metab Toxicol. Feb 2009; 5(2): 131-6 Pubmed[9278]
Czyrak A. Arzneimittelforschung. Feb 1994; 44(2): 113-8 Pubmed[11064]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger, Arzneimittelinteraktionen bei der medikamentösen Epilepsietherapie: ein kritischer Überblick, Nervenheilkunde (Nov. 2007) [2766]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980 Pubmed[12553]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980. Nov 0207; 26(11): 969-980 Pubmed[12554]
D'Arrigo C. Pharmacol Res. Dec 2005; 52(6): 497-501 Pubmed[2687]
D'Cunha R. Biopharm Drug Dispos. Oct 2016; 37(7): 397-408 Pubmed[7615]